AHR Activation Is Protective against Colitis Driven by T Cells in Humanized Mice

Existing therapies for inflammatory bowel disease that are based on broad suppression of inflammation result in variable clinical benefit and unwanted side effects. A potential therapeutic approach for promoting immune tolerance is the in vivo induction of regulatory T cells (Tregs). Here we report...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Cell reports (Cambridge) Ročník 17; číslo 5; s. 1318 - 1329
Hlavní autori:	Goettel, Jeremy A., Gandhi, Roopali, Kenison, Jessica E., Yeste, Ada, Murugaiyan, Gopal, Sambanthamoorthy, Sharmila, Griffith, Alexandra E., Patel, Bonny, Shouval, Dror S., Weiner, Howard L., Snapper, Scott B., Quintana, Francisco J.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States Elsevier Inc 25.10.2016 Elsevier
Predmet:	AHR Animals Colitis - immunology Colitis - metabolism Disease Models, Animal Forkhead Transcription Factors - metabolism humanized mice Humans IBD ITE Mice Receptors, Aryl Hydrocarbon - metabolism T-Lymphocytes, Regulatory - immunology Thiazoles Transforming Growth Factor beta1 - pharmacology treg Trinitrobenzenesulfonic Acid IBD AHR ITE treg humanized mice
ISSN:	2211-1247, 2211-1247
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!